AVITA Medical (RCEL) Non-Current Deffered Revenue (2019 - 2026)
AVITA Medical's (RCEL) quarterly Non-Current Deffered Revenue came in at $290000.0 in Q4 2025, down 10.49% YoY from $324000.0 in Q4 2024, and down 2.68% on a QoQ basis from $298000.0 in Q3 2025.
AVITA Medical (RCEL) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 7 years of Non-Current Deffered Revenue data on file, last reported at $290000.0 in Q4 2025.
- Quarterly Non-Current Deffered Revenue fell 10.49% year-over-year to $290000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $290000.0 (down 10.49% YoY) and the FY2025 annual result came in at $290000.0, down 10.49% from the prior year.
- Non-Current Deffered Revenue slipped to $290000.0 in Q4 2025, from $298000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.1 million in Q2 2021 to a low of $290000.0 in Q4 2025.
- A 5-year average of $561750.0 and a median of $369500.0 in 2023 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2021 — Non-Current Deffered Revenue jumped 152.87% — and 2023, when it tumbled 56.69%.
- Tracing RCEL's Non-Current Deffered Revenue over 5 years: stood at $952000.0 in 2021, then declined by 26.68% to $698000.0 in 2022, then plunged by 48.85% to $357000.0 in 2023, then slipped by 9.24% to $324000.0 in 2024, then dropped by 10.49% to $290000.0 in 2025.
- The last three Non-Current Deffered Revenue figures came in at $290000.0 (Q4 2025), $298000.0 (Q3 2025), and $307000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | AVITA Medical | 311.65 Mn | 300.52 Mn | 17.77 Mn | 273,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 273,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | 298,000.00 |
| Jun 30, 2025 | 307,000.00 |
| Mar 31, 2025 | 315,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Sep 30, 2024 | 332,000.00 |
| Jun 30, 2024 | 340,000.00 |
| Mar 31, 2024 | 349,000.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | 365,000.00 |
| Jun 30, 2023 | 374,000.00 |
| Mar 31, 2023 | 382,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 740,000.00 |
| Jun 30, 2022 | 813,000.00 |
| Mar 31, 2022 | 882,000.00 |
| Dec 31, 2021 | 952,000.00 |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.10 Mn |